2seventy bio Profit Margin

The latest profit margin for TSVT is -8.46% as of March 2025. That compares with -313.51% in the prior-year period — up 97.3% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside 2seventy bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, TSVT's profit margin moved from -313.51% to -8.46% — a 97.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 2seventy bio's valuation or profitability profile.

Against its sector companies, TSVT currently prints -8.46% for profit margin, while the sector average sits near 13.23%. That is roughly 164.0% below the sector mean. Large gaps often invite a closer look at 2seventy bio's growth, margins, and balance sheet.

Profit Margin shows how effectively 2seventy bio converts resources into returns. At -8.46%, TSVT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -313.51% in the prior-year period — up 97.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TSVT's profit margin (-8.46%), review year-over-year change from -313.51%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.